bioRN News
Cytion is a global leader in authenticated cell lines, serving as a trusted repository of high-quality, contamination-free biological resources. Founded in 2004 as Cell Lines Service, the company has curated over 1,000 cell lines from diverse tumors, tissues, and species. Its mission is to safeguard scientific assets and provide researchers with reliable research reagents. With […]
read more
Biotechnologie-Branche tagt im Life Science Hot Spot Heidelberg
Heidelberg 9. April 2025: Mehr als 1000 Teilnehmerinnen und Teilnehmer aus dem Biotech-Sektor sind heute in Heidelberg zu ihrer jährlichen Konferenz, den Deutschen Biotechnologietagen, eingetroffen. Unternehmerinnen und Unternehmer, Wissenschaftler sowie Vertreterinnen und Vertreter aus Politik, Administration und Medien tauschen sich hier für zwei Tage über die neuesten Entwicklungen in der Branche und die Rahmenbedingungen für […]
read more
New Member: Welcome in our cluster to WuXi AppTec
WuXi AppTec is a pharmaceutical, biotechnology, and medical device R&D service provider with operations in China and the U.S. Its China-based services cover the entire discovery and development process, from hit-to-lead and preclinical development to clinical drug production and commercialization. In the U.S., the company offers integrated laboratory and manufacturing services for biologics and medical […]
read more
New Member: Welcome in our cluster to CAVIGEN UG
CAVIGEN develops thermoformed microstructures for cell culture, including microcavities, porous microcavities, sensor-integrated microcavities (sensor arrays), and microchannels. Its patented technology enables precise oxygen measurement in 3D cell cultures, enhancing the physiological relevance of in vitro models, improving drug development processes, and reducing the need for animal testing. CAVIGEN’s business model follows a razor-and-blade approach, offering […]
read more
Deutschlands wichtigste Wette auf die Zukunft
Handelsblatt | 07.02.2025 Biotechnologie zählt zu den vielversprechendsten Wirtschaftsfeldern. Die Bundesrepublik zeigt dabei laut einer neuen Studie überraschende Stärken. Experten sehen allerdings Probleme, die dringend gelöst werden müssen. Der deutsche Mikrobiologe Robert Koch findet 1882 den Erreger für die Krankheit Tuberkulose. 1895: Wilhelm Conrad Röntgen entdeckt in Würzburg durch Zufall die Röntgenstrahlen. 1897: Ein Chemiker der Bayer […]
read more
New Member: Welcome in our cluster to Menarini Biotech
Menarini Biotech (MBH) is a leading CDMO specializing in Process Development and GMP manufacturing across various therapeutic areas. With a mission to be a reliable, agile, and innovative partner, MBH empowers its customers to bring life-saving biotherapeutics to patients through expertise in drug development. From lab to production, cutting-edge technology accelerates processes, optimizes yields, and […]
read more
New Member: Welcome in our cluster to GeneTechX
At GeneTechX, they are developing a nutrigenomics platform that combines genetics and nutritional science to create personalized dietary solutions. Leveraging advanced gene-editing technologies like PrimeCRISPR, they investigate the intricate relationships between genes, diet, and health outcomes. By identifying genetic variations that affect nutrient metabolism, GeneTechX delivers tailored nutrition strategies to enhance health and prevent disease, […]
read more
New Member: Welcome in our cluster to Akribion Therapeutics GmbH
Akribion Therapeutics is developing a unique, RNA-guided, nuclease-based technology for programmable cell depletion. Its G-dase® E nuclease has the ability to kill cells by shredding DNA and RNA, but only if there is a highly specific match between the guide RNA and an intracellular RNA sequence. This ensures that only the targeted cells are affected, […]
read more
New Member: Welcome in our cluster to Alcedis GmbH
Alcedis is a globally operating, leading full-service CRO with over 30 years of experience in clinical research. As a member of the Huma Group, they combine deep expertise with innovative AI-driven technologies to conduct clinical trials efficiently and accurately – from Phase I to market authorization, medical device projects, and real-world evidence. Their in-house competence […]
read more
